Skip to main content
Scope Forward

Scope Forward

By Praveen Suthrum

No one in the medical field is free from the impact of COVID-19, including gastroenterologists. But the pandemic has only accelerated trends that started years ago. In this podcast, Praveen Suthrum interviews leaders in the gastroenterology space. Each episode will take you through different perspectives and help you ask the right questions. Praveen is the President of NextServices and author of Private Equity in Gastroenterology and Scope Forward (both Amazon #1 new releases).
Available on
Apple Podcasts Logo
Google Podcasts Logo
Pocket Casts Logo
RadioPublic Logo
Spotify Logo
Currently playing episode

GB Pratt, CEO of ModifyHealth: We are a 100% aligned to where healthcare is heading

Scope Forward Jan 29, 2021

00:00
14:56
Dr. Aja McCutchen: A new startup in women's gut health

Dr. Aja McCutchen: A new startup in women's gut health

Praveen Suthrum interviews Dr. Aja McCutchen, Co-Founder, OLVI Health Dive deep with Dr. Aja McCutchen, as she unveils her groundbreaking venture into women's gut health. This conversation is essential for anyone interested in the nexus of gastroenterology, women's health, and innovation.

Highlights:
Addressing the Gap in Women's Gut Health: Dr. McCutchen discusses the severe lack of data and tailored healthcare solutions for women facing gastrointestinal issues, emphasizing the need for specialized care. She outlines how her 40,000 women patient years of experience led to the formation of OLVI Health, a startup focused on addressing these unmet needs.
The Foundation and Mission of OLVI Health: The co-founders' journey began at a regional conference, sparking a shared vision to tackle the unique challenges women face in gastroenterology. Dr. McCutchen, alongside Dr. Asma Khapra and Dr. Latha Alaparthi, aims to transform care through innovative, data-driven solutions, starting with their AI-driven technology platform.
The Role of Technology and Future Vision: Highlighting the innovative use of AI and data analytics, Dr. McCutchen describes how OLVI Health plans to integrate digital health tools to better understand and treat women's GI conditions. She expresses an optimistic future where OLVI not only improves women's health but also serves as a model for how technology can bridge gaps in healthcare.

Dr. Aja McCutchen's call to action is clear: "Jump in the pool and start working on it." Her proactive approach in launching OLVI Health illustrates her commitment to not just understanding women's health challenges but actively solving them with cutting-edge technology and a deep understanding of her patients' needs. #digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #ai #womenshealth #guthealth

Apr 24, 202421:37
Andrea Cherubini: Launching AI apps on GI Genius

Andrea Cherubini: Launching AI apps on GI Genius

Praveen Suthrum interviews Andrea Cherubini, SVP Science, AI and Data, Cosmo IMD Dive into the fascinating world of AI in healthcare with Andrea Cherubini. This episode is a must-listen for anyone captivated by the role of AI in healthcare and particularly within gastroenterology. Cherubini's insights offer a unique window into the future of medicine, where AI not only supports but enhances medical expertise. Highlights: ▶ The Genesis of GI Genius: Andrea Cherubini shares the inception story of Cosmo IMD's collaboration with Medtronic in developing GI Genius, emphasizing the 'perfect storm' of opportunities that led to this revolutionary AI tool in gastroenterology. This narrative underscores the synergy of medical imaging expertise, AI, and pharmaceutical studies in pioneering medical diagnostics. ▶ Human-AI Hybrid Teams in Healthcare: A key takeaway from the conversation is the concept of human-AI hybrid teams. Cherubini articulates how these collaborations enhance the accuracy and effectiveness of medical diagnoses, surpassing the capabilities of human or AI working in isolation. This insight is critical for understanding the future trajectory of AI in healthcare. ▶ Navigating the AI Landscape in Gastroenterology: The interview sheds light on the broader implications of AI in gastroenterology, from real-time AI applications in endoscopy rooms to broader healthcare quality improvements. Cherubini elaborates on the challenges and potential of AI, advocating for responsible and innovative integration of these technologies in healthcare settings. Andrea Cherubini's message resonates with a sense of urgency and vision: the healthcare industry is on the brink of a transformative era with AI. His emphasis on the importance of embracing AI as a tool to augment human skill in medical practice is a clarion call to healthcare professionals worldwide. This conversation is not just an exploration of AI's current state in healthcare but a glimpse into a future where AI and human expertise collectively redefine medical excellence.
#digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #ai

Apr 12, 202430:42
Torrey Smith: Building drone bots for the gut

Torrey Smith: Building drone bots for the gut

Praveen Suthrum interviews Torrey Smith, Co-Founder & CEO, endiatx Dive deep with Torrey Smith, as he shares his groundbreaking journey in the world of medical technology. A fascinating look into the innovative use of drone technology within the field of gastroenterology. Highlights: ▶ From Aerospace to medtech: Torrey Smith shares his journey from aerospace engineering to pioneering medical device technology. Inspired by his personal experiences and science fiction, Smith's transition into medtech was driven by a desire to push the boundaries of what's possible in healthcare. ▶ The Creation of Pillbot™: The story behind the development of Pillbot™ is as intriguing as a sci-fi movie. Smith discusses how this advanced prototype, resembling a tiny quadcopter, is designed to navigate the human stomach. This innovation represents a significant leap in GI tract examination and treatment. ▶ The Future of GI Robotics: Smith envisions the human stomach as the perfect starting point for deploying tiny robots in the human body. He explains how the stomach's unique environment makes it an ideal playground for these swimming drones, potentially revolutionizing diagnostics and treatment in gastroenterology. Torrey Smith's innovative approach in blending deep tech with medtech, particularly in the GI field, marks a significant step forward in the evolution of healthcare technology. His work with endiatx and the development of Pillbot™ could pave the way for new, minimally invasive methods for diagnosing and treating GI conditions.

Mar 20, 202437:51
Dr. Steinberg: If you could put an ultrasound probe on a finger, why couldn't you put it on a scope?

Dr. Steinberg: If you could put an ultrasound probe on a finger, why couldn't you put it on a scope?

Praveen Suthrum interviews Dr. Stephen Steinberg, Founder and Chief Medical Officer at EndoSound Dive deep with Dr. Stephen Steinberg, as he shares his groundbreaking journey in revolutionizing Endoscopic Ultrasound (EUS) technology. This episode is a treasure trove for anyone interested in the intersection of gastroenterology, medical technology, and innovation. Highlights: ▶ The Genesis of a Revolutionary Idea: Dr. Stephen Steinberg recounts the inception of his innovative concept, inspired by technology initially intended for battlefield triage. He explains how the idea of integrating an ultrasound probe on a finger led to the transformative thought of attaching it to an endoscope, paving the way for advancements in gastroenterology. ▶ The Journey of EndoSound: Dr. Steinberg delves into the story of EndoSound, highlighting its mission to make EUS accessible and affordable. He discusses the development of the Endosound Vision System (EVS), a novel technology that transforms existing flexible video gastroscopes into ultrasound endoscopes, thereby democratizing this crucial diagnostic tool. ▶ Impact and Future of Endoscopic Technology: With a career spanning over four decades, Dr. Steinberg shares his insights on the evolution of endoscopic techniques and their impact on patient care. He emphasizes the role of EndoSound in creating better healthcare outcomes by making advanced diagnostics available to a broader range of providers and patients. Join this enlightening conversation with Dr. Stephen Steinberg, as we explore his innovative contributions to gastroenterology and the future of medical devices in enhancing patient care.


#digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #ai

Mar 06, 202440:03
Dr. Sanket Chauhan: "Don't forget that (an endoscopy) robot is part of the team as well"

Dr. Sanket Chauhan: "Don't forget that (an endoscopy) robot is part of the team as well"

Praveen Suthrum interviews Dr. Sanket Chauhan, Founder & CEO at Surgical Automations Dive deep with Dr. Sanket Chauhan, as he shares his insights on the integration of robotics in healthcare, particularly in gastroenterology (GI). This interview is a fascinating exploration for anyone interested in the intersection of robotics, AI, and healthcare. Highlights: ▶ Robotics in Gastroenterology: Dr. Sanket Chauhan discusses the precision and efficiency of robotic movements in medical procedures, emphasizing the mathematical precision and consistency that robots bring to the team. He advocates for the inclusion of robots as integral team members in healthcare. ▶ The Journey to Robotics: Dr. Chauhan shares his background in robotics, starting from his fellowship in Florida and his training under Dr. V.I. Patel, a renowned figure in robotic surgery. His journey reflects a blend of mechanical engineering and medical expertise, leading to innovations in surgical robotics. ▶ The Birth of Surgical Automations: The inception of Surgical Automations is rooted in Dr. Chauhan's vision during the COVID-19 pandemic. He explains how the company's focus initially wasn't on gastroenterology but on respiratory systems due to the pandemic's demands. The company's core technology, an AI-based endoluminal navigation system, is versatile and applicable to various medical fields, including GI. Dr. Sanket Chauhan's perspective on the future of gastroenterology in the context of robotics is enlightening. He says, "Don't forget that a robot is part of the team as well," highlighting the growing importance of robotics in enhancing healthcare delivery.

Feb 22, 202427:46
Dr. Austin Lee Chiang: We need more trained health professionals speaking out on social media

Dr. Austin Lee Chiang: We need more trained health professionals speaking out on social media

Praveen Suthrum interviews Dr. Austin Lee Chiang, Chief Medical Officer at Medtronic Endoscopy Dive deep with Dr. Austin Lee Chiang, as he shares his journey and insights on the intersection of healthcare, social media, and technology. This interview is a must-watch for anyone interested in the evolving landscape of gastroenterology, digital health, and the power of social media in medicine. Highlights: ▶ Social Media Influence: Dr. Chiang has achieved an impressive 180,000,000 views on TikTok and has over 650,000 subscribers across various platforms, demonstrating his significant impact in the digital space. ▶ The White House Meeting: Dr. Chiang discusses his experience at the White House, highlighting the importance of trained health professionals in shaping healthcare policy and the role of social media in these discussions. ▶ The Future of GI and AI: He shares his thoughts on the future of gastroenterology, particularly the emerging role of AI platforms, and teases an exciting announcement from Medtronic in 2024. Dr. Austin Lee Chiang, with his unique blend of medical expertise and social media influence, brings a fresh and impactful perspective to the field of gastroenterology. His insights provide valuable lessons on the importance of embracing technology and social media to advance healthcare.

Feb 09, 202439:58
Saurabh Jejurikar: If you can drive autonomous cars on roads, can you drive endoscopes in patients?

Saurabh Jejurikar: If you can drive autonomous cars on roads, can you drive endoscopes in patients?

Praveen Suthrum interviews Saurabh Jejurikar, Co-founder and CEO at EndoVisionAI

Dive deep with Saurabh Jejurikar, as he explores the intriguing intersection of autonomous technology and medical innovation in gastroenterology. This interview is a must-watch for anyone interested in the cutting-edge advancements in digital health and gastroenterology.

Highlights:

▶ From Autonomous Cars to Endoscopes: Saurabh Jejurikar discusses the unique transition from self-driving technology to the development of autonomous endoscopes. This shift represents a significant leap in applying advanced technology to improve patient care in gastroenterology.

▶ The Genesis of EndoVisionAI: Saurabh shares the origin story of EndoVisionAI, sparked by a conversation about the challenges in gastroenterology. With his co-founder, who has a background in autonomous vehicles, and inspired by his father, a gastroenterologist, they embarked on this innovative journey.

▶ A New Approach to Gastroenterology: The interview delves into how EndoVisionAI is changing the landscape of gastroenterology. By interviewing hundreds of doctors, from seasoned professionals to trainees, the company aims to enhance the quality of care and address the challenges faced by junior doctors in the field.

Saurabh Jejurikar's vision for EndoVisionAI is not just about aiding experienced doctors but also about improving the overall quality of gastroenterological procedures and training. This conversation is a fascinating look at how cross-disciplinary innovation can lead to groundbreaking developments in healthcare. #digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #ai

Jan 24, 202415:12
Dr. Erica Barnell: Non-invasive diagnostics will play an important role in preventing disease

Dr. Erica Barnell: Non-invasive diagnostics will play an important role in preventing disease

Praveen Suthrum interviews Dr. Erica Barnell, Co-Founder & Chief Medical Officer, Geneoscopy Dr. Erica Barnell, discusses the vital role of non-invasive diagnostics in preventing disease. This insightful conversation is a must-watch for anyone interested in the future of gastroenterology, digital health, and precision oncology.

Highlights:

▶ The Importance of Non-Invasive Diagnostics: Dr. Erica Barnell emphasizes the significant role of non-invasive diagnostics in early-stage disease detection and prevention, particularly in colorectal cancer. She advocates for the detection of precancerous conditions rather than late-stage cancers, highlighting the potential of these technologies in changing patient outcomes.

▶ Innovations in Geneoscopy: Dr. Barnell shares updates on Geneoscopy's advancements, including their development of a novel stool-based RNA technology. This technology, awaiting FDA pre-market approval, is recognized as a breakthrough in colorectal cancer screening, especially for individuals under 50.

▶ Collaboration and Research: With her background in bioinformatics and precision oncology, Dr. Barnell discusses her work in developing new products targeting autoimmune and inflammatory diseases. Her collaboration with leading universities and biopharmaceutical companies is pivotal in improving gastrointestinal disease diagnosis, monitoring, and treatment.

Dr. Erica Barnell, a pioneer in medical science, brings her expertise to the forefront in this engaging interview, offering a glimpse into the innovative approaches reshaping the landscape of healthcare diagnostics.

#digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future

Jan 10, 202442:42
Dunston Almeida: The value of data in GI is huge

Dunston Almeida: The value of data in GI is huge

Praveen Suthrum interviews Dunston Almeida, Founder and CEO at triValence

Dive deep with Dunston Almeida, as he explores the transformative power of data in gastroenterology (GI). In his compelling narrative, Dunston Almeida underscores the necessity of integrating technology in GI: "In an era where technology is reshaping every aspect of our lives, the GI sector cannot remain an exception. By embracing innovative solutions and data-driven approaches, we can significantly advance patient outcomes and streamline healthcare delivery."Highlights:

▶ Exploring the Rich Data Landscape in GI: Dunston emphasizes the critical role of data in gastroenterology. He provides insights into how GI practitioners can harness their existing data, even from conventional sources, to significantly enhance their operational efficiency and patient care.

▶ Pioneering Change in the ASC Industry: Dunston addresses the pressing inefficiencies within the ambulatory surgery center (ASC) industry, particularly in the GI sector. He details a technological solution that streamlines supply chain processes, makes payments efficient, and offers advanced market analytics.

▶ The Path of a Healthcare Tech Innovator: Dunston Almeida's 25-year journey in the health-tech is nothing short of remarkable. From his academic roots at Cornell University to his transformative roles in companies like Zelis and eviCore, Dunston has consistently pushed the boundaries of innovation.

#digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #data

Dec 20, 202334:07
Prof. David C. Whitcomb: Old paradigm of germ theory doesn't work. We need Precision Medicine.

Prof. David C. Whitcomb: Old paradigm of germ theory doesn't work. We need Precision Medicine.

Praveen Suthrum interviews David C. Whitcomb, MD, PhD, Co-founder & Chief Scientific Officer at Ariel Precision Medicine #gastroenterology #gi #thescopeforwardshow #nextservices #digitalhealth #future

Dec 06, 202342:42
Asaf Kraus: AI-based stool recognition aids Uber engineer support GI care delivery

Asaf Kraus: AI-based stool recognition aids Uber engineer support GI care delivery

Praveen Suthrum interviews Asaf Kraus Founder & CEO, Dieta Health Dive deep with Asaf Kraus, Founder & CEO of Dieta Health, as he explores the innovative application of Artificial Intelligence (AI) in gastroenterology, particularly in stool analysis. This conversation is a must-watch for those interested in the intersection of technology and healthcare, especially in digestive health. Highlights: ▶ AI in Stool Recognition for GI Care: Asaf Kraus discusses the groundbreaking work of Dieta Health in using AI for stool analysis. He explains how AI can outperform patients in predicting what a human gastroenterologist would diagnose, based on the analysis of stool images. ▶ Personal Journey to Innovation: Living with IBS himself, Asaf's personal health challenges led him to a profound realization about the lack of data-driven personalization in gastroenterology. This epiphany was the catalyst for founding Dieta Health, aiming to revolutionize digestive health care through data and AI. ▶ From Uber Engineer to GI Innovator: Asaf shares his transition from being a data scientist at Uber to applying his expertise in machine learning to gastroenterology. His unique approach to applying AI in healthcare demonstrates the vast potential of technology in transforming medical diagnosis and treatment. Asaf Kraus's journey is not just a professional endeavor but a personal mission to make gastroenterology smarter, more tailored, and ultimately more human. His work at Dieta Health is paving the way for a future where AI leads in providing personalized solutions for digestive health challenges. #thescopeforwardshow #digitalhealth #innovation #gastroenterology

Nov 23, 202342:18
Dr. Michael Byrne: The elephant in the room is reimbursement. Who's going to pay for AI in GI?

Dr. Michael Byrne: The elephant in the room is reimbursement. Who's going to pay for AI in GI?

Nov 02, 202341:29
Dr. Bara El Kurdi: What young GIs really want

Dr. Bara El Kurdi: What young GIs really want

Praveen Suthrum interviews Dr. Bara El Kurdi, Assistant Professor of Gastroenterology & Hepatology, Virginia Tech Carilion School of Medicine | Host, GI Startup Podcast #thescopeforwardshow #gastroenterology #digitalhealth

Oct 04, 202346:30
Omer Dror, CEO of Lynx.MD: Data as a new ancillary

Omer Dror, CEO of Lynx.MD: Data as a new ancillary

In a world where lines between technology and healthcare blur more each day, I recently had the privilege of conversing with Omer Dror, CEO of Lynx.MD. Our dialogue ventured into the transformative realm of AI, the untapped potential of data, and the inevitable digital shift in gastroenterology. Self-driving cars once seemed a distant dream but today it's more than a reality. Similarly, present advancements in AI and data analytics are reshaping healthcare in ways we're only beginning to grasp. Highlights: ▶ The AI Revolution: Beyond mere automation, AI stands poised to redefine patient care, from intricate endoscopy procedures to holistic medical record analyses. ▶ Data's Uncharted Territory: As we've seen in other industries, data is a treasure trove waiting to be harnessed. But how do we extract and refine this "new oil"? ▶ The Gastroenterologist's Role: Amidst this tech whirlwind, the GI clinician remains central -- provided GIs step up to lead. Delve into our conversation. It's not just a glimpse into the future; it's a roadmap to navigate what's to come. Data indeed is an emerging ancillary - tap into it. Here's the interview. #thescopeforwardshow #gastroenterology #data #digitalhealth

Sep 21, 202339:56
Dr. Russ Arjal: "You've to break rules to do something that's transformational"

Dr. Russ Arjal: "You've to break rules to do something that's transformational"

Dr. Russ Arjal, co-founder and chief medical officer of Telebelly Health, joins The Scope Forward show to discuss the future of gastroenterology and the role of technology in reshaping the field. With a focus on patient-centric care and the integration of AI, Dr. Arjal provides a comprehensive overview of the challenges and opportunities facing GI practitioners today.
Watch this super insightful interview.


Aug 23, 202339:08
Dr. Daniel Neumann : There are several risks in GI right now, we need to adapt to changes
Aug 02, 202347:22
Sam Jactel, CEO of Ayble Health: “Being patient centered is different than being patient driven”

Sam Jactel, CEO of Ayble Health: “Being patient centered is different than being patient driven”

At the end of the interview, Sam Jactel, GI patient turned CEO talks about Thomas Nagel the philosopher. In a paper from 1974, Nagel famously asked us to contemplate “What is it like to be a bat?” He suggested that you may be able to study the behavior of a bat but you can never really know what it’s like to be one. Sam takes that analogy to his own GI condition. He was tired of looking for answers within the industry. He was tired of not being seen or heard. And he ended up figuring out a solution that worked for him. Then he thought why not help other patients like him. That prompted him to go from being the CEO of his own condition to becoming the founder and CEO of Ayble Health. This digital GI startup has raised $4.6 million from investors. Watch this incredible interview. It’s a sign of the times. Expect more patients to become digital healthcare providers because the industry isn’t stepping up enough.
Jan 20, 202335:04
AGA launches GI Opportunity Fund

AGA launches GI Opportunity Fund

In this episode, Praveen Suthrum interviews Tom Serena (CEO, American Gastroenterological Association), Matt Schwartz (CEO & Co-founder, Virgo) and Andrea Vossler (Co-founder & Managing Director, Varia Ventures).

* Scope Forward has always been about finding the way forward for gastroenterology. Naturally I was excited that a leading GI society such as the American Gastroenterological Association (AGA) was scoping forward by launching a venture capital fund called the GI Opportunity Fund (in partnership with Varia Ventures).  What was even more exciting is that AGA chose to invest in Virgo to launch the fund. I interviewed Virgo's cofounder Matt Schwartz earlier this year - we talked about the value of data in GI.  In this interview, you'll learn from Tom Serena (CEO of AGA) on why (and  how) AGA chose to go down the route of venture investing. How the market opportunity for GI is enormous. How to invest and participate in this fund? If you are an entrepreneur, how to land an investment.  More importantly, you'll understand the central premise of this interview. As Andrea Vossler, Cofounder and Managing Director of Varia Ventures said, physicians are the epicenter of medical care. You are the ones who are innovating. It's time to step forward and make your ideas into a reality. If you listen closely, Matt has this one piece of advice for GI entrepreneurs.  *

Dec 23, 202232:03
Dr. Jonathan Ng (CEO of Iterative Health): Not using computer vision is a barrier to health equity

Dr. Jonathan Ng (CEO of Iterative Health): Not using computer vision is a barrier to health equity

I asked Jonathan Ng, founder and CEO of Iterative Health (formerly known as Iterative Scopes, an AI in GI startup) why investors recently gave them $150 million in funding. We didn't exactly get to the answer but I can fathom a thesis.

Iterative Health's investors include the founders of Flatiron: Nat Turner and Zach Weinberg. A digital health company that advances cancer research. Pharma company Roche acquired Flatiron for $1.9 billion in 2018. Other investors of Iterative Health include Johnson & Johnson and Eli Lilly amongst others. Further key team members from Flatiron have been joining Iterative. 

My reading of the play here is straightforward. It's possible that investors want to repeat their thesis of Flatiron for Iterative but in gastroenterology. Big Pharma is funding AI in healthcare to develop more targeted therapy for the drugs they develop. Therefore the central premise of Iterative's offerings today seem to be on better recruitment for clinical trials. Physicians get an ancillary. Pharma automates patient recruitment.

I came away super impressed with Jon's unwavering vision for AI in GI: equitable healthcare. When I asked how Iterative is different from Medtronic or others who were also working AI in GI. He repeated his vision - he said the desire for equitable healthcare differentiated them.

While on a medical mission in Cambodia, it occurred to him that not all doctors are made equal. And that means patients can't get fair access to healthcare. Computer vision and AI could change that. He took action. 

Jon moved to MIT to study MBA and build on this idea. In a very short period, he developed the foundation for Iterative that went onto pave the way for AI in GI.

Here's Jon changing gastroenterology for good. It's reasonable to say that the future of GI hinges on the execution of his vision.

Nov 10, 202231:47
Dr. Michael Owens: "What would I do with my time if I am not doing as many colonoscopies?"

Dr. Michael Owens: "What would I do with my time if I am not doing as many colonoscopies?"

Gastroenterologist Dr. Michael Owens did a thought experiment during the pandemic period. He asked himself, what would I do with my time if I'm not doing as many colonoscopies?

That question led him to leave his large GI group to start up a multi-specialty GI group that takes advantage of the trends shaping the future of GI. For example, trends such as value based care, the microbiome, AI, colonics, single-use devices, genomic tests, liquid biopsy and so on. As he implies, Mike literally implemented the central premise of the book Scope Forward to build future on his own terms. He stands as a great example for GI 2.0.

We often limit our choices to what's prevalent in the market. Join a hospital. Join PE. Merge with a large independent group. Kudos to Mike and his partners at Pearl Health Partners for having the courage to go against the grain and take a different, innovative approach. 

He says in the interview: if not now then when?

Nov 07, 202237:59
Dr. Kosinski: “GI is more vulnerable today than it was before” (SF interview)

Dr. Kosinski: “GI is more vulnerable today than it was before” (SF interview)

Dr. Larry Kosinski needs no introduction. As a leader, he's known for innovating, for breaking away from the norm and be a guiding light for the industry.  After a successful private practice career, he helped his group transition to a PE platform to work on SonarMD, a venture-funded company he founded. Now, he's onto a surprising new startup, a stool-smelling e-nose called Voconomics (patent filed). 

In this freewheeling interview, we chat about everything that GI doctors must pay attention to. The risks of running non-diversified "colonoscopy factories" (as he calls them). The shift to digital that would catch most of the industry by surprise. How doctors can find the time from their busy lives to innovate by mastering the basics. And finally his take on private equity.

This is such an important interview. It could quite easily alter the trajectory of many GI careers. It's time to wake up to the vulnerability that private practice GI is in. Dr. Kosinski's message is quite clear. Listen closely.
Sep 23, 202250:03
Erik Duhaime (CEO, Centaur Labs): Networks of people & computers will work together

Erik Duhaime (CEO, Centaur Labs): Networks of people & computers will work together

Data is indeed the new oil.  

Consider the strangeness of the scenario. GI doctors are supplying the fuel everyday that's going to set the old norm on fire but don't realize it. Because they are too busy generating the data!

The wrong approach to this scenario is to fear this shift to digital and block it. You really can't. It's multiplying exponentially. The right approach is to figure out how to play the game or prepare for this changing scenario. Educate yourself on the future of GI and go there before the industry gets there.

Erik's company Centaur Labs helps AI medical companies cleanup and annotate the data that GI and other specialties generate. They do so by taking a crowdsourced approach. Thousands of medical students from around the world label polyps and other medical information via a gamified app. Centaur gives that labeled data back to Medical AI companies. Those companies in turn feed that data to the AI so that the AI learns the right approach to care.

I  kept asking  Erik how much time we have before AI becomes mainstream in GI. He initially said, we are early in the cycle. It's still far out. I persisted. Finally, he said we are possibly 5 years away.

As Erik refers to a quote on AI, it's not about the AI replacing doctors. But the future belongs to doctors who will understand the AI and replace those who don't.

Don't miss this one. Your future self will thank you for it.

Sep 12, 202249:45
Greg O'Grady: As clinicians, some of our skills may become relatively obsolete

Greg O'Grady: As clinicians, some of our skills may become relatively obsolete

As I write this note, I'm beginning to wonder what GI care means anymore. Just a few years ago, we were so sure of the role of the gastroenterologist in clinical care. Today, a flurry of digital innovations are urging the clinician to rethink her/his role. Surgeon and scientist and CEO of Alimetry, Professor Greg O'Grady reaffirmed how exponential technologies could make current clinical skills relatively obsolete.

Gastric Alimetry is a FDA approved device (below) that non-invasively senses motility of the stomach. Sensors capture activity of the stomach, relay it to an app, advanced algorithms spot patterns and generate a report for the clinician. It's fascinating technology that's been in the works at the University of Auckland, New Zealand for a decade.

Interestingly, in my book Scope Forward, I briefly talked about researchers working on a wearable device to track electrical activity of the digestive system and how algorithms would flag abnormalities (Page 51). Today it's a commercial reality. The future is indeed coming at us faster than we think!

Don't miss this one.

Aug 11, 202226:39
Dr. Haytham Gareer: RNA stool test with 95% accuracy to increase colonoscopies

Dr. Haytham Gareer: RNA stool test with 95% accuracy to increase colonoscopies

In this episode of The Scope Forward Show, Praveen Suthrum interviews Dr. Haytham Gareer, Chief Medical Officer, Geneoscopy (RNA stool testing company). 

In November 2021, a month after Dr. Haytham Gareer joined Geneoscopy as CMO, the company raised $105 million in funding. The company is developing an RNA analysis platform to detect colorectal cancer (to be launched in 2023).

A clinical study showed that when compared against the gold-standard colonoscopy, the platform demonstrated better sensitivity data in detecting advanced adenomas and colorectal cancer than other non-invasive tests.

Dr. Gareer says Geneoscopy is going to increasing the number of colonoscopies being performed. However, it's obvious to me that digital biology is disrupting not just GI but many other specialties that are diagnosing cancer.

I couldn't hold my curiosity and asked quite directly. Should gastroenterologists be worried about them? Should Cologuard be worried? Should Medtronic with its AI-based polyp detection system be worried? Because when there's a test that's going to detect adenomas with a fair degree of accuracy, why bother with diagnostic procedures? Dr. Gareer had a different and interesting view.

As readers of Scope Forward, you already know my take. With more data, digital biology innovations such as RNA and DNA tests combined with machine learning would get extremely sophisticated. It'll even be able to predict things that we just can't with traditional approaches. Dr. Haytham completely agreed.

Jul 28, 202238:58
Sonia Grego: Oura Ring for sleep. WHOOP for activity. Now, Coprata Smart Toilet for stool.

Sonia Grego: Oura Ring for sleep. WHOOP for activity. Now, Coprata Smart Toilet for stool.

In this episode of The Scope Forward Show, Praveen Suthrum interviews Sonia Grego (Duke Professor and Co-Founder at Coprata Inc). The Coprata toilet captures lots of data post flush, runs #AI algorithms on the data and provides the analysis to both patients and doctors.

Watch this insightful interview to understand why smart toilets are essential for proactive (not reactive) GI care.

Watch the interview- https://lnkd.in/dkY4qmpE

#data #digitalhealth #gastroenterology #ibs #stool #ai #engineering #innovation #scopeforward

Jul 22, 202228:30
Demand is so high for GI psych - Dr. Riehl (Michigan Medicine) & Dr. Simons (Cleveland Clinic)

Demand is so high for GI psych - Dr. Riehl (Michigan Medicine) & Dr. Simons (Cleveland Clinic)

While COVID was on and people sought help through meditation apps, the business world of behavioral health made a big announcement. Headspace (an app started by a former Buddhist monk) merged with Ginger.io to create Headspace Health in a $3 billion merger. You read that right.

It's only natural that behavioral health showed up in gastroenterology. Curious, I reached out to GI psychologists Dr. Megan Riehl from Michigan Medicine and Dr. Madison Simons from Cleveland Clinic. What were these large institutions up to in this space? Why were they hiring psychogastroenterologists? Was there patient demand for something like this? What role would cognitive behavior therapy play in digital health?

This is an evolving space with high demand - especially for those GI conditions that don't have straightforward solutions. Mental health and its role in the making and management of GI conditions is a space to watch.

The brain-gut axis has a definite role to play in GI's future. Watch this one.

Jul 07, 202236:50
Matt Schwartz: Huge opportunity to add a digital layer to GI and endoscopy

Matt Schwartz: Huge opportunity to add a digital layer to GI and endoscopy

In this episode of The Scope Forward Show, Praveen Suthrum interviews Matt Schwartz CEO & Co-founder of Virgo.

Virgo has captured 400,000 endoscopy videos so far and that number is growing exponentially. Virgo has also partnered with pharmaceutical companies to recruit the right candidates for clinical trials which led to a fundraise of $8 million with FCA Venture Partners and a soon-to-be-announced strategic investor.

Watch this insightful interview to understand why 'data is the new oil' and how Virgo will dramatically influence GI care in the coming years-https://www.youtube.com/watch?v=5XUvl7RDzsQ

#data #gastroenterology #scopeforward #endoscopy #AI #clinicaltrials

Jun 30, 202238:17
Dr. Fehmida Chipty: From GI doc to COO of digital health startup

Dr. Fehmida Chipty: From GI doc to COO of digital health startup

In this episode of The Scope Forward Show, Praveen Suthrum interviews Fehmida Chipty, MD, COO of digital health startup Satya Health Sciences | NovoLiver.

Watch Dr. Fehmida Chipty's fascinating narration unfold fundamental issues of #gastroenterology. Why did she quit GI? What are the problems that we don't talk about? Why don't physicians ask for help? What her concerns are with our healthcare system? Is doing #colonoscopy after colonoscopy really helping solve for cancer?


Your future self will want you to watch this one.

Jun 23, 202237:44
Abe M'Bodj: How Will Private Equity Respond To Recession?

Abe M'Bodj: How Will Private Equity Respond To Recession?

In this episode of The Scope Forward Show, Praveen Suthrum interviews Abe M'Bodj, Vice President at Westcove Partners, a leading healthcare-focused investment bank. During an economic downturn, would PE investments increase or drop? About 10% of the entire gastroenterology industry is under some form of PE as of mid-2022. What effect would recession have on "second bites" (exits) of existing PE platforms? What impact would it have on valuations? What big announcements can we expect before the end of the year? Find out more in this exclusive interview.

Jun 16, 202243:43
Aonghus Shortt: "If you capture more data, you should be able to do a better diagnosis."

Aonghus Shortt: "If you capture more data, you should be able to do a better diagnosis."

We are back with the next season of The Scope Forward Show where you'll get to meet innovators and leaders who are reimagining the healthcare system.

The next phase of GI depends on innovators such as
Aonghus and FoodMarble. Why? Because the industry is shifting from under our feet. Four trends are influencing GI: exponential technologies, consolidation, big brothers (such as hospitals, insurances) and changes in patient behavior.

FoodMarble, a tiny device that analyzes digestive disorders such as IBS and SIBO, comes squarely in the middle of these trends. After selling 30,000 devices, what do they know about patients with IBS that a private practice does not? How can this be a new revenue-generating ancillary opportunity? 

The story of its growth is also interesting. An engineer gets an idea after seeing his girlfriend suffer. Ideates and develops the device in Ireland and China. Raises $6 million and sells globally - more than 2/3rd in the US. It's indicative of how the next phase of innovation would happen.

Aonghus says, with "more data", you can come up with a "better diagnosis". True. Welcome to the evolving world of data-driven GI.

Jun 09, 202224:38
Dr. Sravanthi Parasa: "When a phone can recognize my face, why can’t software recognize a polyp?"

Dr. Sravanthi Parasa: "When a phone can recognize my face, why can’t software recognize a polyp?"

Every so often an interview reminds me yet again that the future is coming at us faster -- much faster. I'm still wrapping my head around what gastroenterologist and AI researcher Dr. Sravanthi Parasa told me: there would be a "1,000 algorithms" in 3 years in GI.

This is big implications for the business of gastroenterology. The AI will indeed operate and guide us like a self driving car. In such a world, how would your role evolve as the endoscopist? What would happen to all the PE valuations that are based on GI manual productivity? How would the workflow change when you combine liquid biopsy and AI? Would your practice prefer hiring an AI vs. an average endoscopist? What if the insurance mandates the use of AI?

Welcome to GI 2.0.

**

Watch more interviews:  https://www.nextservices.com/interviews/

**

#gastroenterology #TheScopeForwardShow #nextservices​​ #scopeforward​​ #healthcare​​ #technology​​ #healthtech​​ #aiingi #artificialintelligence #digitalhealth

Nov 25, 202135:54
Sam Holliday (CEO of Oshi Health): "My goal would be to cover all 50 states by the end of 2022."
Oct 29, 202129:56
Dr. Aja McCutchen: "How can we be so under-represented and expect to make a big change?"
Oct 14, 202131:46
PE Platform US Digestive: "There's Still Tremendous Green Space Within GI"
Sep 06, 202148:28
CEO of Bold Health: "We seek to cover all GI conditions you might want to see a doctor for"

CEO of Bold Health: "We seek to cover all GI conditions you might want to see a doctor for"

Elena Mustatea is the CEO and founder of Bold Health, a digital GI company that delivers digital therapeutics for the treatment of various GI conditions such as IBS. Their first app Zemedy is available in 190 countries. Now, they are hiring GIs and expanding in the US.

In 2018, Forbes listed Elena in a 30 under 30 list.

While private practice GIs are occupied with private equity, the world of digital health has been expanding. In Q1 2021, digital health attracted $9 billion in investments. 

In this first-of-its-kind interview, learn more about Bold Health and the world of digital therapeutics, CBT, integrative medicine and the advent of digital health in GI. Elena talks about their business and operational models. She delves into getting paid by insurances.

Digital GI is a practical reality today. This train too is leaving the station.

#gastroenterology #bolhealth #futureofhealthcare #scopeforward #TheScopeForwardShow 

May 28, 202126:17
How to start clinical research as an ancillary in gastroenterology

How to start clinical research as an ancillary in gastroenterology

Praveen Suthrum, President of NextServices interviews Dr. Narayanachar Murali (South Carolina), Dr. Don Lazas (ObjectiveGI, Tennessee) and Dr. Chris Fourment (CRSG and Precision Research, Texas). Learn how to start clinical research as an ancillary.

In this interview, you’ll learn three different perspectives on clinical trials/research as an ancillary in a GI practice. We’ll explore the pros/cons, costs, risks, and operating models.  

Consider this interview as a primer on starting up with clinical trials/research. In the coming weeks, we’ll release more detailed interviews on the topic. 

****  

Read the full transcript of this interview here - http://www.nextservices.com/how-to-start-clinical-trials-research-as-an-ancillary-in-gastroenterology/

****  

SCOPE FORWARD - Releasing on 26th August, 2020.  Visit our website now: http://scope-forward.com/

****  

#clinicaltrials#ObjectiveGI#gastroenterology#CRSG#IBD#NASH#NAFLD#liverdiseases#hepatology#scopeforward#solopractice#risks#healthcare#medicine#ancillaries#pharmaceuticals#trials#research

May 06, 202130:51
Dr. Scott Ketover: The future of GI remains bright (Interview)
Apr 27, 202128:13
Author of VRx Dr. Brennan Spiegel: Virtual Reality in Gastroenterology

Author of VRx Dr. Brennan Spiegel: Virtual Reality in Gastroenterology

Dr. Brennan Spiegel is the author of VRx: How Virtual Therapeutics Will Revolutionize Medicine. He’s the Director of Health Services Research, Cedars-Sinai Health System. This is a historic, one-of-a-kind interview. It lays out the digital future for GI from the lens of virtual reality (VR). Dr. Spiegel and his team have seen 3,000 patients via VR. The technology is no more new. FDA is approving solutions. Medicare is due to pay for VR. The challenge of private practice GI is to diversify from colonoscopy. Could VR be a new ancillary stream? Find out. Do not miss this one (35+ mins).

**** 

#VirtualReality#gastroenterology#TheScopeForwardShow#VRx#AR#futureofhealthcare#medicine#healthcare

Apr 21, 202134:35
AGA talk: What must you know when considering PE (8 factors, 4 risks)
Apr 01, 202135:51
Rock Rockett: Yes, you can stay small and independent. But it's a qualified yes
Mar 24, 202118:01
Dr. Baig and Dr. Gialanella: “Shift will occur when there’s financial hardship. And it’ll occur pretty quickly as we see screening colonoscopy going down”

Dr. Baig and Dr. Gialanella: “Shift will occur when there’s financial hardship. And it’ll occur pretty quickly as we see screening colonoscopy going down”

New Jersey-based Allied Digestive Health recently became the 8th private equity platform in gastroenterology. In this interview, Dr. Robert Gialanella, CEO/President and Dr. Nadeem Baig, Vice President of Allied Digestive Health talk about their journey – from being competitors to partners to choosing private equity and more. Learn about how they consolidated without private equity first, building the largest GI group in New Jersey. They talk about the “generational divide” between the senior and junior partners and reflected on how they tackled this situation at Allied. They also shared their views on consolidations, disruptions, and EBITDA assumptions. Finally, they laid out four trends as gastroenterology moves to the future. Watch this direct and lucid interview in full to understand the evolving landscape of GI.

Read the entire transcript here - https://www.nextservices.com/interview-with-dr-bob-gialanella-and-dr-nadeem-baig-allied-digestive-health/

Mar 16, 202132:12
Gastrologix: "We create companies that physicians can have ownership in"

Gastrologix: "We create companies that physicians can have ownership in"

Praveen Suthrum, President at NextServices interviews Chris Metz and Steve Somers from Gastrologix, a GPO (Group Purchasing Organization).  

**** 

Read the entire transcript of the interview here - https://www.nextservices.com/interview-with-gastrologix-we-create-companies-that-physicians-can-have-ownership-in/
  

**** 

Scope Forward: The Future of Gastroenterology Is Now in Your Hands is now live on Amazon! Get your copies now - https://geni.us/scopeforward
 

**** 

What if you could own companies you spend money on? What if you could save money on routine purchases by getting bulk rates? With those ideas, Christopher Metz and Stephen Somers founded Gastrologix, a Group Purchasing Organization (GPO). Gastrologix is the first GI-specific GPO that works with independent gastroenterologists. Today, they count 75 GI practices in their growing network.  

Watch this interview to understand on-the-ground insights from a GI-specific GPO.

****

#gastroenterology #GPO #Gastrologix #nextservices #independentpractices #cost #savings #DHN #medicine #healthcare #scopeforward #ancillaries #infusion #vendorfunded

Mar 10, 202113:01
Dr. Gene Overholt: "Always do the right thing. And the right thing is what's best for the patient"

Dr. Gene Overholt: "Always do the right thing. And the right thing is what's best for the patient"

Praveen Suthrum, President at NextServices and Author, Scope Forward interviews Dr. Bergein Overholt.   

**** 

Dr. Bergein F. Overholt needs no introduction. He founded the Gastrointestinal Associates in Knoxville and led the group for four decades.  He is also the past president of the American Society for Gastrointestinal Endoscopy and American Association of Ambulatory Surgery Centers. 

Dr. Overholt helped develop the flexible fibersigmoidoscope-colonscope, for which he earned many awards. In 1986, his efforts resulted in the establishment of the nation’s first GI single specialty Ambulatory Surgery Center. Dr. Overholt has also taught many of today’s GI practice leaders how to develop and manage their own GI-ASCs.

In this one-of-a-kind interview, Dr. Overholt walks us through his four-decade-long journey, reflects on the new technologies, private equity, and shares his views on alignment among physicians. And finally, he shares timely and relevant advice for gastroenterologists.

At a time when gastroenterology is at crossroads, Dr. Overholt says what needs to be said. Watch on. Don’t miss the story of how the country’s first GI ASC started.

Read the transcript here - https://www.nextservices.com/interview-with-dr-gene-overholt-always-do-the-right-thing/

#gastroenterology #futureofhealthcare 

Mar 03, 202125:10
Giovanni Di Napoli, President, Medtronic GI: Will AI replace gastroenterologists?

Giovanni Di Napoli, President, Medtronic GI: Will AI replace gastroenterologists?

Feb 24, 202119:56
Dr. Ellen Scherl: We must reclaim our role as healers

Dr. Ellen Scherl: We must reclaim our role as healers

Praveen Suthrum, President of NextServices interviews Dr. Ellen Scherl, Founding Director of the Jill Roberts Center for Inflammatory Bowel Disease.

**** 

Scope Forward: The Future of Gastroenterology Is Now in Your Hands is now live on Amazon! Get your copies now - https://geni.us/scopeforward​ 

**** 

Dr. Ellen Scherl is the Research Director and Founding Director of the Jill Roberts Center for Inflammatory Bowel Disease (IBD), Weill Cornell Medicine. Dr. Scherl has recently been honored with the Rosenthal Humanitarian Award from the Crohn’s and Colitis Foundation. Dr. Scherl is known nationally and internationally for her work in the field of IBD.

Feb 15, 202126:58
Dr. Michael Weinstein, President & CEO of Capital Digestive Care (Part 2): "Adapt or die...standing still is not a zero risk option"
Feb 08, 202118:26
Dr. Michael Weinstein, President & CEO of Capital Digestive Care (Part 1): “This is about what you want to be in 2030”

Dr. Michael Weinstein, President & CEO of Capital Digestive Care (Part 1): “This is about what you want to be in 2030”

Praveen Suthrum, President, NextServices interviews Dr. Michael Weinstein, President & CEO of Capital Digestive Care and Past President, DHPA. Dr. Weinstein is also a member of the governing board at the AGA Institute.  

Dr. Weinstein's interview is loaded with so many insights that we will be releasing it in two parts. Each part deserves to be watched in full.

In this video, you'll learn how Capital Digestive Care grew to be 60+ providers is a story that's relevant to many groups looking to consolidate regionally. In 2018, they went on a strategy planning retreat to decide what they'd like to be in 2030. That led to the partnership with Physicians Endoscopy.  

Dr. Weinstein outlines the benefits of their MSO to private GI practices and how it differs from private equity.

Feb 03, 202126:11
GB Pratt, CEO of ModifyHealth: We are a 100% aligned to where healthcare is heading

GB Pratt, CEO of ModifyHealth: We are a 100% aligned to where healthcare is heading

George “G.B.” Pratt is the Founder and CEO of #ModifyHealth​. The company recently raised $2 million in #SeriesAfunding​ – right in the middle of the pandemic.  As a “food as medicine” company, ModifyHealth provides fresh, Low-FODMAP and Gluten-free meals to patients suffering from GI conditions. GI practices partner with the company to benefit from a dietary ancillary.  In this interview, you’ll learn more about ModifyHealth’s business model. A big question GB reflects on is whether ModifyHealth goes against the grain of today’s healthcare model.

Jan 29, 202114:56
Dr. Partha Nandi (Pinnacle GI): “We are clearly in the third inning of private equity investments in GI” (not eighth)

Dr. Partha Nandi (Pinnacle GI): “We are clearly in the third inning of private equity investments in GI” (not eighth)

On November 30th, 2020, Troy Gastroenterology (Michigan) announced its partnership with H.I.G. Growth Partners to launch the seventh private equity platform in GI: Pinnacle GI Partners.
Dr. Partha Nandi is the President, Practice CEO and Executive Chair of the Board of the new platform. In this insightful interview, he shares why it’s still an early inning for private equity in gastroenterology, how they chose their PE partner and discusses challenges with EBITDA expectations.

Listen to this exclusive deep dive into GI’s latest PE platform.

Jan 19, 202123:25
Dr. John Allen (Michigan): "[Expect] pretty stiff headwinds for many years to come"

Dr. John Allen (Michigan): "[Expect] pretty stiff headwinds for many years to come"

John Allen, M.D is the Chief Clinical Officer of the University of Michigan Medical Group and is also on the board of Allina Health. In 2019, AGA presented its highest honor, the Julius Friedenwald Medal for his contributions to gastroenterology. Previously, he was the chief of Digestive Diseases at Yale and helped build Minnesota Gastroenterology (now MNGI), one of the largest GI practices in the country.  

This interview is so insightful that it'll help you make several business and personal decisions for the long haul. Here's specifically what you'll take away:  

1) What does it take lead calmly and steadily through a crisis? Especially a large health system 

2) Planning for another pandemic (or another wave) should it occur 

3) Fundamental shifts in GI and US healthcare economics that we are not yet recognizing 

4) Weighing pros and cons of private equity 

5) Future of gastroenterology - technology, consolidation, ethics and morals

Jan 14, 202146:36